Similarly, Zhang et al. found that MCAM expression was present in 46.61% of squamous cell carcinoma cases and 37.47% of adenocarcinoma cases in NSCLC and was statistically associated with a reduced 5-year survival (P = 0.037) [152]. This evidence concerns the gene MCAM and non-small cell lung carcinoma.